Poster 99-LB at #ADA2020 by @danamlewis, @azure_dominique, and Lance Kriegsfeld, “Multi-Timescale Interactions of Glucose and Insulin in Type 1 Diabetes Reveal Benefits of Hybrid Closed Loop Systems“
Background - Blood glucose and insulin exhibit coupled biological rhythms at multiple timescales, including hours (ultradian, UR) and the day (circadian, CR) in individuals without diabetes. But, biological rhythms in longitudinal data have not been mapped in T1D. #ADA2020
It is not known exactly how glucose and insulin rhythms compare between T1D and non-T1D, and whether rhythms are affected by type of therapy (Sensor Augmented Pump (SAP) or Hybrid Closed Loop (HCL)). #ADA2020
Data & Methods:
We assessed stability and amplitude of normalized continuous glucose and insulin rate oscillations using the continuous wavelet transformation and wavelet coherence. #ADA2020
Data came from 16 non-T1D individuals (CGM only, >2 weeks per individual) from the Quantified Self CGM dataset & 200 (n=100 HCL, n=100 SAP; >3 months per individual) individuals from the @Tidepool_org Big Data Donation Project. Morlet wavelets were used for all analyses. #ADA2020
Morlet wavelets were used for all analyses. Data were analyzed & plotted using Matlab 2020a, Python 3 in conjunction with in-house code for wavelet decomposition modified from “Jlab” toolbox, (code, Dr. Tanya Leise) and Wavelet Coherence toolkit (@cuixu). #ADA2020
Linear regression was used to generate correlations, and paired t-tests were used to compare AUC for wavelet and wavelet coherences by group (df=100). Stats used 1 point per individual per day. #ADA2020
Wavelets Assess Glucose Insulin Rhythms and Interactions
^ Morlet wavelets (A) estimate rhythmic strength in glucose or insulin data at each minute in time (a combination of signal amplitude and oscillation stability) by assessing the fit of a wavelet stretched in window and in the x and y dimensions to a signal (B). #ADA2020
The output (C) is a matrix of wavelet power, periodicity, & time (days). Transform of example HCL data illustrate predominantly circadian power in glucose, & predominantly 1-6 h ultradian power in insulin.Color map indicates wavelet power (synonymous with Y axis height). #ADA2020
Wavelet coherence (D) enables assessment of rhythmic interactions between glucose and insulin; here, glucose and insulin rhythms are highly correlated at the 3-6 (ultradian) and 24 (circadian) hour timescales. #ADA2020
Results:
Hybrid Closed Loop Systems Reduce Hyperglycemia. See the visualization glucose distribution of SAP, HCL, and non-T1D. #ADA2020
HCL Improves Correlation of Glucose-Insulin Level and Rhythm, compared to SAP. #ADA2020
Hybrid Closed Looping Results in Greater Coherence than SAP.
(Non-T1D individuals have highly coherent glucose and insulin at the circadian and ultradian timescales, but these relationships had not previously been assessed in T1D.) #ADA2020
Glucose-insulin coherence is significantly higher in HCL than in SAP.
This shows circadian (blue) and 3-6 hour ultradian (maroon) coherence of glucose and insulin in HCL (solid) and SAP (dotted) users. Transparent shading indicates standard deviation. #ADA2020
Although both HCL and SAP individuals have lower coherence than would be expected in a non-T1D individual, HCL CR and UR coherence are significantly greater than SAP CR and UR coherence (paired t-test p= 1.51*10-7 t=-5.77 and p= 5.01*10-14 t=-9.19, respectively). #ADA2020
This brings HCL users’ glucose and insulin closer to the canonical non-T1D phenotype than SAP users’. #ADA2020
Additionally, the amplitude of HCL users’ glucose CRs and URs (solid) is closer (smaller) to that of non-T1D (dashed) individuals than are SAP glucose rhythms (dotted). #ADA2020
SAP CR and UR amplitude is significantly higher than that of HCL or non-T1D (T-test,1,98, p= 2.47*10-17 and p= 5.95*10-20, respectively), but HCL CR amplitude is not significantly different from non-T1D CR amplitude (p=0.61). #ADA2020
Together, HCL users are more similar than SAP users to the canonical Non-T1D phenotype in A) rhythmic interaction between glucose and insulin and B) glucose rhythmic amplitude. #ADA2020
Conclusions, Future Directions:
T1D and non-T1D individuals exhibit different relative stabilities of within-a-day rhythms and daily rhythms in blood glucose, and T1D glucose and insulin delivery rhythmic patterns differ by insulin delivery system. #ADA2020
HCL is associated w/greater correlation between glucose & insulin delivery rate, between ultradian glucose & insulin delivery rhythms; greater circadian & ultradian coherence between glucose & insulin, and lower amplitude swings than in SAP. #ADA2020
These preliminary results suggest that HCL recapitulates non-diabetes glucose-insulin dynamics to a greater degree than SAP. #AA2020
Future work is needed to analyze HCL system type, insulin type, etc that may influence rhythmic structure, as well as determining if stability of rhythmic structure is associated with greater time in range to help determine if bolstering rhythmic structure helps in T1D. #ADA2020
Acknowledgements: Thanks to all of the individuals who donated their data as part of the @Tidepool_org Big Data Donation Project, as well as the @OpenAPS Data Commons, from which data is also being used in other areas of this study, and @JDRF for study funding. #ADA2020
(/end)
(You can find a longer written form version of this poster content, a PDF version to download, and all other posters co-authored by @danamlewis from #ADA2020 at bit.ly/DanaMLewisADA2…).
• • •
Missing some Tweet in this thread? You can try to
force a refresh
1/ What if there was a tool to help identify who might have exocrine pancreatic insufficiency (EPI/PEI)?
EPI is a significant issue for many people with diabetes (likely more common than gastroparesis or celiac).
Here's how such a tool can help PWD👇🏼🧵
#ADASciSessions #ADA2024
2/ The Exocrine Pancreatic Insufficiency Symptom Score (EPI/PEI-SS) has 15 symptoms, rated by how frequent they are and how bothersome they are (aka severity).
n=324 ppl participated in a real-world survey.
n=118 were people with diabetes (PWD)!
#ADASciSessions #ADA2024
3/ Methods:
EPI/PEI-SS scores were analyzed and compared between PWD (n=118), with EPI (T1D: n=14; T2D: n=20) or without EPI (T1D: n=78; T2D: n=6), and people without diabetes (n=206) with and without EPI.
📣 Presentation of the primary outcome results from the CREATE Trial, which assessed open source automated insulin delivery (AID) compared to sensor-augmented pump therapy (SAPT) in adults & kids with T1D, at #ADA2022!
The CREATE trial aimed to study the efficacy and safety of an open source automated insulin delivery system, with a large scale, long term randomized controlled trial.
I just realized it's been 3 (!) years since I published my book on automated insulin delivery, with the goal of helping increased conversation and understanding of AID technology for people with diabetes, their loved ones, and healthcare providers!
I'm still very proud that it is available to read for free online, free to download a PDF (both of which have been done thousands of times each: ArtificialPancreasBook.com), or as an e-book, paperback, and now hardback copy. Proceeds from the purchased copies go to Life For A Child.
And, more recently, it has also been translated into French by the wonderful Dr. Mihaela Muresan and Olivier Legendre!
The French translation is available in Kindle, paperback, hardback, or free PDF download formats as well.
1/THREAD - my presentation is kicking off at #EASD2020 about open source automated insulin delivery.
(You can see a full version of my presentation here: bit.ly/DanaMLewisEASD…, or read the summary below!)
Note we should differentiate between open source (where the source of something is open), and DIY (do-it-yourself) implementations of open source code. Open source means it can be reviewed and used by individuals (thus, DIY or #DIYAPS) or by companies.
Poster 988-P at #ADA2020 by Jennifer Zabinsky, Haley Howell, Alireza Ghezavati, @DanaMLewis Andrew Nguyen, and Jenise Wong: “Do-It-Yourself Artificial Pancreas Systems Reduce Hyperglycemia Without Increasing Hypoglycemia”
This was a retrospective double cohort study that evaluated data from the @OpenAPS Data Commons (data ranged from 2017-2019) and compared it to conventional sensor-augmented pump (SAP) therapy from the @Tidepool_org Big Data Donation Project. #ADA2020
One month of CGM data (with more than 70% of the month spent using CGM), as long as they were >1 year of living with T1D, was used from the @OpenAPS Data Commons. People could be using any type of DIYAPS (OpenAPS, Loop, or AndroidAPS) and there were no age restrictions. #ADA2020
At #DData2020 today, I got to present (virtually!) a study called “AID-IRL”, which was an opportunity to learn from several people using commercial automated insulin delivery systems in the real world.
Here’s more information about the study, and what I learned!
THREAD:
1/ I did semi-structured phone interviews with 7 users of commercial AID systems in the last few months. The study was funded by @DiabetesMine. Study participants received $50 for their participation. #DData2020
2/ I sought a mix of longer-time and newer AID users, using a mix of systems. Control-IQ (4) and 670G (2) users were interviewed; as well as (1) a CamAPS FX user since it was approved in the UK during the time of the study. #DData2020